Tremeau Pharmaceuticals
Cambridge
About Tremeau Pharmaceuticals
Tremeau Pharmaceuticals is a Massachusetts based privately funded clinical stage company focused on commercializing non-opioid pain therapies targeting serious rare diseases impacted by the cyclooxygenase (COX) or prostanoid pathways. They focus exclusively on orphan or unique disease states with high unmet medical need.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $115.2M
- Funding stage: Private Equity
- Last round: Private Equity (Dec 2020)
- Website: tremeaurx.com
- Phone: [email protected]
Industries & Categories
Clinical Trials, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/tremeau-pharmaceuticals-125555 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.